特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
959871

抗ウイルス療法の世界市場:COVID-19の影響とタイプ別、作用機序別、用途別、地域別の分析

Anti-Viral Therapies Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type ; Mechanism of Action ; Application and Geography

出版日: | 発行: The Insight Partners | ページ情報: 英文 170 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.15円
抗ウイルス療法の世界市場:COVID-19の影響とタイプ別、作用機序別、用途別、地域別の分析
出版日: 2020年08月20日
発行: The Insight Partners
ページ情報: 英文 170 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の抗ウイルス療法の市場規模は、2019年の405億8,979万米ドルから2027年には762億8,263万米ドルに拡大すると予測されており、2020年から2027年までのCAGRは8.3%になる見通しです。市場拡大の原動力となるのは、製薬企業の研究開発費増加、研究活動や臨床試験に対する各国政府の支援拡大などの要因です。一方、医薬品開発に必要な費用の高騰は、成長の足かせとなります。

当レポートは、世界の抗ウイルス療法市場を調査したもので、市場の概況や力学、タイプ別、作用機序別、用途別、地域別の分析、新型コロナウイルス感染症(COVID-19)パンデミックの影響、業界の情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 イントロダクション

第2章 主な調査結果

第3章 調査手法

第4章 市場の情勢

  • 概要
  • PEST分析
  • 専門家の見解

第5章 市場の主な力学

  • 市場成長促進要因
  • 市場成長阻害要因
  • 市場機会
  • 今後の動向
  • 影響分析

第6章 世界市場の分析

  • 収益予測と分析
  • 地域別の予測と分析
  • 主要企業の市場でのポジショニング

第7章 市場分析:タイプ別

  • 概要
  • ジェネリック医薬品
  • ブランド医薬品

第8章 市場分析:作用機序別

  • 概要
  • ヌクレオチドポリメラーゼ阻害剤
  • 逆転写酵素阻害剤
  • プロテアーゼ阻害剤
  • その他

第9章 市場分析:用途別

  • 概要
  • HIV
  • 肝炎
  • ヘルペス
  • インフルエンザ
  • その他

第10章 各地域の分析

  • 北米
  • 欧州
  • アジア太平洋
  • 中東・アフリカ
  • 中南米

第11章 COVID-19パンデミックの影響

  • 北米
  • 欧州
  • アジア太平洋
  • その他

第12章 業界の情勢

  • 概要
  • 各社の成長戦略
  • 有機的発展
  • 無機的発展

第13章 企業プロファイル

  • Abbott
  • AbbVie Inc.
  • Bristol-Myers Squibb Company
  • Johnson and Johnson Services, Inc.
  • Merck & Co., Inc.
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc.
  • AstraZeneca
  • Aurobindo Pharma Ltd
  • F. HOFFMANN-LA ROCHE LTD.

第14章 付録

図表

List Of Tables

  • Table 1. R&D Investments by Major Pharmaceutical Companies
  • Table 2. North America Anti-Viral Therapies Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 3. North America Anti-Viral Therapies Market, by Mechanism of Action - Revenue and Forecast to 2027 (USD Million)
  • Table 4. North America Anti-Viral Therapies Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 5. US Anti-Viral Therapies Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 6. US Anti-Viral Therapies Market, by Mechanism of Action- Revenue and Forecast to 2027 (USD Million)
  • Table 7. US Anti-Viral Therapies Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 8. Canada Anti-Viral Therapies Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 9. Canada Anti-Viral Therapies Market, by Mechanism of Action- Revenue and Forecast to 2027 (USD Million)
  • Table 10. Canada Anti-Viral Therapies Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 11. Mexico Anti-Viral Therapies Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 12. Mexico Anti-Viral Therapies Market, by Mechanism of Action- Revenue and Forecast to 2027 (USD Million)
  • Table 13. Mexico Anti-Viral Therapies Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 14. Europe Anti-Viral Therapies Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 15. Europe Anti-Viral Therapies Market, by Mechanism of Action - Revenue and Forecast to 2027 (USD Million)
  • Table 16. Europe Anti-Viral Therapies Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 17. Germany Anti-Viral Therapies Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 18. Germany Anti-Viral Therapies Market, by Mechanism of Action- Revenue and Forecast to 2027 (USD Million)
  • Table 19. Germany Anti-Viral Therapies Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 20. UK Anti-Viral Therapies Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 21. UK Anti-Viral Therapies Market, by Mechanism of Action- Revenue and Forecast to 2027 (USD Million)
  • Table 22. UK Anti-Viral Therapies Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 23. France Anti-Viral Therapies Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 24. France Anti-Viral Therapies Market, by Mechanism of Action- Revenue and Forecast to 2027 (USD Million)
  • Table 25. France Anti-Viral Therapies Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 26. Spain Anti-Viral Therapies Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 27. Spain Anti-Viral Therapies Market, by Mechanism of Action- Revenue and Forecast to 2027 (USD Million)
  • Table 28. Spain Anti-Viral Therapies Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 29. Italy Anti-Viral Therapies Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 30. Italy Anti-Viral Therapies Market, by Mechanism of Action- Revenue and Forecast to 2027 (USD Million)
  • Table 31. Italy Anti-Viral Therapies Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 32. Asia Pacific Anti-Viral Therapies Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 33. Asia Pacific Anti-Viral Therapies Market, by Mechanism of Action - Revenue and Forecast to 2027 (USD Million)
  • Table 34. Asia Pacific Anti-Viral Therapies Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 35. China Anti-Viral Therapies Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 36. China Anti-Viral Therapies Market, by Mechanism of Action- Revenue and Forecast to 2027 (USD Million)
  • Table 37. China Anti-Viral Therapies Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 38. Japan Anti-Viral Therapies Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 39. Japan Anti-Viral Therapies Market, by Mechanism of Action- Revenue and Forecast to 2027 (USD Million)
  • Table 40. Japan Anti-Viral Therapies Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 41. India Anti-Viral Therapies Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 42. India Anti-Viral Therapies Market, by Mechanism of Action- Revenue and Forecast to 2027 (USD Million)
  • Table 43. India Anti-Viral Therapies Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 44. South Korea Anti-Viral Therapies Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 45. South Korea Anti-Viral Therapies Market, by Mechanism of Action- Revenue and Forecast to 2027 (USD Million)
  • Table 46. South Korea Anti-Viral Therapies Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 47. Australia Anti-Viral Therapies Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 48. Australia Anti-Viral Therapies Market, by Mechanism of Action- Revenue and Forecast to 2027 (USD Million)
  • Table 49. Australia Anti-Viral Therapies Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 50. Middle East & Africa Anti-Viral Therapies Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 51. Middle East & Africa Anti-Viral Therapies Market, by Mechanism of Action - Revenue and Forecast to 2027 (USD Million)
  • Table 52. Middle East & Africa Anti-Viral Therapies Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 53. Saudi Arabia Anti-Viral Therapies Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 54. Saudi Arabia Anti-Viral Therapies Market, by Mechanism of Action - Revenue and Forecast to 2027 (USD Million)
  • Table 55. Saudi Arabia Anti-Viral Therapies Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 56. UAE Anti-Viral Therapies Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 57. UAE Anti-Viral Therapies Market, by Mechanism of Action - Revenue and Forecast to 2027 (USD Million)
  • Table 58. UAE Anti-Viral Therapies Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 59. South Africa Anti-Viral Therapies Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 60. South Africa Anti-Viral Therapies Market, by Mechanism of Action - Revenue and Forecast to 2027 (USD Million)
  • Table 61. South Africa Anti-Viral Therapies Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 62. South and Central America Anti-Viral Therapies Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 63. South and Central America Anti-Viral Therapies Market, by Mechanism of Action - Revenue and Forecast to 2027 (USD Million)
  • Table 64. South and Central America Anti-Viral Therapies Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 65. Brazil Anti-Viral Therapies Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 66. Brazil Anti-Viral Therapies Market, by Mechanism of Action - Revenue and Forecast to 2027 (USD Million)
  • Table 67. Brazil Anti-Viral Therapies Market, by Application- Revenue and Forecast to 2027 (USD Million)
  • Table 68. Argentina Anti-Viral Therapies Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 69. Argentina Anti-Viral Therapies Market, by Mechanism of Action - Revenue and Forecast to 2027 (USD Million)
  • Table 70. Argentina Anti-Viral Therapies Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 71. Organic Developments Done By Companies
  • Table 72. Inorganic Developments Done by Companies
  • Table 73. Glossary of Terms, Anti-Viral Therapies Market

List Of Figures

  • Figure 1. Anti-Viral Therapies Market Segmentation
  • Figure 2. Anti-Viral Therapies Market Segmentation, By Region
  • Figure 3. Anti-Viral Therapies Market Overview
  • Figure 4. Branded Drugs Segment Held Largest Share of Anti-Viral Therapies Market
  • Figure 5. APAC to Show Significant Growth During Forecast Period
  • Figure 6. Anti- Viral Therapies Market, by Geography (US$ Million)
  • Figure 7. Global Anti -Viral Therapies Market - Leading Country Markets (US$ Million)
  • Figure 8. Global Anti-Viral Therapies Market, Industry Landscape
  • Figure 9. North America PEST Analysis
  • Figure 10. Europe PEST Analysis
  • Figure 11. Asia Pacific PEST Analysis
  • Figure 12. Middle East and Africa (MEA) PEST Analysis
  • Figure 13. South and Central America (SCAM) PEST Analysis
  • Figure 14. Anti-Viral Therapies Market Impact Analysis of Driver and Restraints
  • Figure 15. Global Anti-Viral Therapies Market - Revenue Forecast And Analysis - 2019- 2027
  • Figure 16. Global Anti- Viral Therapies Market - By Geography Forecast and Analysis - 2019- 2027
  • Figure 17. Market Positioning Of Key Players In Global Anti- Viral Therapies Market
  • Figure 18. Anti-viral therapies market Revenue Share, by Type (2019 and 2027)
  • Figure 19. Generic Drugs: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 20. Branded Drugs: Anti-viral therapies market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 21. Anti-Viral Therapies Market Revenue Share, by Mechanism Of Action (2019 and 2027)
  • Figure 22. Nucleotide Polymerase Inhibitor: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 23. Reverse Transcriptase Inhibitors: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 24. Protease Inhibitors: Anti-viral therapies market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 25. Others: Anti-viral therapies market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 26. Anti-Viral Therapies Market Share, by Application, 2019 and 2027 (%)
  • Figure 27. HIV: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 28. Hepatitis: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 29. Herpes: Anti-viral therapies market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 30. Influenza: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 31. Other Applications: Anti-viral therapies market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 32. North America: Anti-Viral Therapies Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 33. North America Anti-Viral Therapies Market Revenue and Forecast to 2027 (USD Million)
  • Figure 34. North America: Anti-Viral Therapies Market, by Country, 2019 & 2027 (%)
  • Figure 35. US: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 36. Canada: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 37. Mexico: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 38. Europe: Anti-Viral Therapies Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 39. Europe Anti-Viral Therapies Market Revenue and Forecast to 2027 (USD Million)
  • Figure 40. Europe: Anti-Viral Therapies Market, by Country, 2019 & 2027 (%)
  • Figure 41. Germany: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 42. UK: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 43. France: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 44. Spain: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 45. Italy: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 46. Asia Pacific: Anti-Viral Therapies Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 47. Asia Pacific Anti-Viral Therapies Market Revenue and Forecast to 2027 (USD Million)
  • Figure 48. China: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 49. Japan: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 50. India: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 51. South Korea: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 52. Australia: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 53. Middle East & Africa: Anti-Viral Therapies Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 54. Middle East & Africa Anti-Viral Therapies Market Revenue and Forecast to 2027 (USD Million)
  • Figure 55. Middle East & Africa: Anti-Viral Therapies Market, by Country, 2019 & 2027 (%)
  • Figure 56. Saudi Arabia: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 57. UAE: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 58. South Africa: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 59. South and Central America: Anti-Viral Therapies Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 60. South and Central America Anti-Viral Therapies Market Revenue and Forecast to 2027 (USD Million)
  • Figure 61. South and Central America: Anti-Viral Therapies Market, by Country, 2019 & 2027 (%)
  • Figure 62. Brazil: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 63. Argentina: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 64. Impact of COVID-19 Pandemic in North American Country Markets
  • Figure 65. Impact of COVID-19 Pandemic in Europe Country Markets
  • Figure 66. Impact of COVID-19 Pandemic in Asia-Pacific Country Markets
  • Figure 67. Impact of COVID-19 Pandemic in Rest of World Country Markets
  • Figure 68. Growth Strategies Done by the Companies in the Market, (%)
目次
Product Code: TIPRE00012650

Title:
Anti-Viral Therapies Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type (Generic Drugs, Branded Drugs); Mechanism of Action (Nucleotide Polymerase Inhibitor, Reverse Transcriptase Inhibitors, Protease Inhibitors, Others); Application (HIV, Hepatitis, Virus Influenza, Herpes, Other Applications) and Geography.

The global anti - viral therapies market is expected to reach US$ 76,282.63 million by 2027 from US$ 40,589.79 million in 2019; it is estimated to grow at a CAGR of 8.3% from 2020 to 2027. The growth of the anti - viral therapies market is mainly attributed to the increasing R&D expenditures by pharmaceutical companies, and rising government support for research activities and clinical trials. However, the high cost of drug development hinders the market growth.

R&D is an essential part of a company's business. Pharmaceutical companies focus on R&D to introduce new drugs with enhanced medical and commercial potential. R&D activities also enable them to launch high-quality and innovative products or re-launch their existing products with significant upgrades. According to the report of the Pharmaceutical Research and Manufacturers of America (PhRMA), R&D expenditure of biopharmaceutical companies increased from US$ 49.6 billion in 2012 to US$ 58.8 billion in 2015. In the fiscal year 2014-2015, 16 pharmaceutical companies were among the world's top 50 companies in terms of total R&D investment. Novartis, Roche, Johnson & Johnson, and Pfizer are among the top 10 leading R&D investing companies globally. For example, Astellas Pharma invested US$ 2,083 million in the R&D of new and advanced drugs. Thus, such high R&D expenditure is anticipated to drive the antiviral therapies market during the forecast period.

Based on type, the anti - viral therapies market is segmented into generic drugs and branded drugs. The branded drugs segment held a larger share of the market in 2019. However, the market for generic drugs segment is estimated to grow at the highest CAGR in the market during the forecast period. Based on mechanism of action, the market is segmented into nucleotide polymerase inhibitors, reverse transcriptase inhibitors, protease inhibitors, and others. Based on application, the anti-viral therapies market is segmented into HIV, hepatitis, herpes, virus influenza, and other applications.

The World Health Organization (WHO), China Food and Drug Administration, Pharmaceutical Research and Manufacturers of America, National Health Commission (NHC) of China, Centers for Disease Control and Prevention (CDC), and European Federation of Pharmaceutical Industries and Associations, along with company websites, are a few of the major primary and secondary sources cited while preparing this report.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the anti - viral therapies market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global anti - viral therapies market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Anti - Viral Therapies Market - By Type
    • 1.3.2 Global Anti - Viral Therapies Market - By Mechanism of Action
    • 1.3.3 Global Anti-viral therapies market - By Application
    • 1.3.4 Global Anti - Viral Therapies Market - By Geography

2. Anti-Viral Therapies Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Global Anti-Viral Therapies - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America - PEST Analysis
    • 4.2.2 Europe - PEST Analysis
    • 4.2.3 Asia Pacific - PEST Analysis
    • 4.2.4 Middle East and Africa (MEA) - PEST Analysis
    • 4.2.5 South and Central America (SCAM) - PEST Analysis
  • 4.3 Expert Opinions

5. Anti-Viral Therapies Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing R&D Expenditures in Pharmaceutical Companies
    • 5.1.2 Rising Government Support for Research Activities and Clinical Trials
  • 5.2 Market Restraints
    • 5.2.1 High Cost of Drug Development
  • 5.3 Market Opportunities
    • 5.3.1 Emerging Markets
  • 5.4 Future Trends
    • 5.4.1 Growing Emphasis on Launching Anti-Viral Agents
  • 5.5 Impact analysis

6. Anti-Viral Therapies Market - Global Analysis

  • 6.1 Global Anti-Viral Therapies Market Revenue Forecast And Analysis
  • 6.2 Global Anti- Viral Therapies Market, By Geography - Forecast And Analysis
  • 6.3 Market Positioning of Key Players

7. Anti - Viral Therapies Market Analysis - By Type

  • 7.1 Overview
  • 7.2 Anti-viral therapies market Revenue Share, by Type (2019 and 2027)
  • 7.3 Generic Drugs
    • 7.3.1 Overview
    • 7.3.2 Generic Drugs: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.4 Branded Drugs
    • 7.4.1 Overview
    • 7.4.2 Branded Drugs: Anti-viral therapies market - Revenue and Forecast to 2027 (US$ Million)

8. Anti-Viral Therapies Market Analysis - By Mechanism of Action

  • 8.1 Overview
  • 8.2 Anti-Viral Therapies Market Revenue Share, by Mechanism Of Action (2019 and 2027)
  • 8.3 Nucleotide Polymerase Inhibitor
    • 8.3.1 Overview
    • 8.3.2 Nucleotide Polymerase Inhibitor: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.4 Reverse Transcriptase Inhibitors
    • 8.4.1 Overview
    • 8.4.2 Reverse Transcriptase Inhibitors: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.5 Protease Inhibitors
    • 8.5.1 Overview
    • 8.5.2 Protease Inhibitors: Anti-viral therapies market - Revenue and Forecast to 2027 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Anti-viral therapies market - Revenue and Forecast to 2027 (US$ Million)

9. Anti-Viral Therapies Market Analysis - By Application

  • 9.1 Overview
  • 9.2 Anti-Viral Therapies Market Share, by Application, 2019 and 2027, (%)
  • 9.3 HIV
    • 9.3.1 Overview
    • 9.3.2 HIV: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.4 Hepatitis
    • 9.4.1 Overview
    • 9.4.2 Hepatitis: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.5 Herpes
    • 9.5.1 Overview
    • 9.5.2 Herpes: Anti-viral therapies market - Revenue and Forecast to 2027 (US$ Million)
  • 9.6 Influenza
    • 9.6.1 Overview
    • 9.6.2 Influenza: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.7 Other Applications
    • 9.7.1 Overview
    • 9.7.2 Other Applications: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (US$ Million)

10. Anti-Viral Therapies Market - Geographic Analysis

  • 10.1 North America: Anti-Viral Therapies Market
    • 10.1.1 Overview
    • 10.1.2 North America: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
    • 10.1.3 North America: Anti-Viral Therapies Market, by Type, 2018-2027 (USD Million)
    • 10.1.4 North America: Anti-Viral Therapies Market, by Mechanism of Action, 2018-2027 (USD Million)
    • 10.1.5 North America: Anti-Viral Therapies Market, by Application, 2018-2027 (USD Million)
    • 10.1.6 North America: Anti-Viral Therapies Market, by Country, 2019 & 2027 (%)
    • 10.1.7 US: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.1 US: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.2 US: Anti-Viral Therapies Market, by Type, 2018-2027 (USD Million)
      • 10.1.7.3 US: Anti-Viral Therapies Market, by Mechanism of Action, 2018-2027 (USD Million)
      • 10.1.7.4 US: Anti-Viral Therapies Market, by Application, 2018-2027 (USD Million)
    • 10.1.8 Canada: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.1 Canada: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.2 Canada: Anti-Viral Therapies Market, by Type, 2018-2027 (USD Million)
      • 10.1.8.3 Canada: Anti-Viral Therapies Market, by Mechanism of Action, 2018-2027 (USD Million)
      • 10.1.8.4 Canada: Anti-Viral Therapies Market, by Application, 2018-2027 (USD Million)
    • 10.1.9 Mexico: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.1 Mexico: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.2 Mexico: Anti-Viral Therapies Market, by Type, 2018-2027 (USD Million)
      • 10.1.9.3 Mexico: Anti-Viral Therapies Market, by Mechanism of Action, 2018-2027 (USD Million)
      • 10.1.9.4 Mexico: Anti-Viral Therapies Market, by Application, 2018-2027 (USD Million)
  • 10.2 Europe: Anti-Viral Therapies Market
    • 10.2.1 Overview
    • 10.2.2 Europe: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
    • 10.2.3 Europe: Anti-Viral Therapies Market, by Type, 2018-2027 (USD Million)
    • 10.2.4 Europe: Anti-Viral Therapies Market, by Mechanism of Action, 2018-2027 (USD Million)
    • 10.2.5 Europe: Anti-Viral Therapies Market, by Application, 2018-2027 (USD Million)
    • 10.2.6 Europe: Anti-Viral Therapies Market, by Country, 2019 & 2027 (%)
    • 10.2.7 Germany: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.7.1 Germany: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.7.2 Germany: Anti-Viral Therapies Market, by Type, 2018-2027 (USD Million)
      • 10.2.7.3 Germany: Anti-Viral Therapies Market, by Mechanism of Action, 2018-2027 (USD Million)
      • 10.2.7.4 Germany: Anti-Viral Therapies Market, by Application, 2018-2027 (USD Million)
    • 10.2.8 UK: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.8.1 UK: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.8.2 UK: Anti-Viral Therapies Market, by Type, 2018-2027 (USD Million)
      • 10.2.8.3 UK: Anti-Viral Therapies Market, by Mechanism of Action, 2018-2027 (USD Million)
      • 10.2.8.4 UK: Anti-Viral Therapies Market, by Application, 2018-2027 (USD Million)
    • 10.2.9 France: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.9.1 France: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.9.2 France: Anti-Viral Therapies Market, by Type, 2018-2027 (USD Million)
      • 10.2.9.3 France: Anti-Viral Therapies Market, by Mechanism of Action, 2018-2027 (USD Million)
      • 10.2.9.4 France: Anti-Viral Therapies Market, by Application, 2018-2027 (USD Million)
    • 10.2.10 Spain: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.10.1 Spain: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.10.2 Spain: Anti-Viral Therapies Market, by Type, 2018-2027 (USD Million)
      • 10.2.10.3 Spain: Anti-Viral Therapies Market, by Mechanism of Action, 2018-2027 (USD Million)
      • 10.2.10.4 Spain: Anti-Viral Therapies Market, by Application, 2018-2027 (USD Million)
    • 10.2.11 Italy: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.11.1 Italy: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.11.2 Italy: Anti-Viral Therapies Market, by Type, 2018-2027 (USD Million)
      • 10.2.11.3 Italy: Anti-Viral Therapies Market, by Mechanism of Action, 2018-2027 (USD Million)
      • 10.2.11.4 Italy: Anti-Viral Therapies Market, by Application, 2018-2027 (USD Million)
  • 10.3 Asia Pacific: Anti-Viral Therapies Market
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
    • 10.3.3 Asia Pacific: Anti-Viral Therapies Market, by Type, 2018-2027 (USD Million)
    • 10.3.4 Asia Pacific: Anti-Viral Therapies Market, by Mechanism of Action, 2018-2027 (USD Million)
    • 10.3.5 Asia Pacific: Anti-Viral Therapies Market, by Application, 2018-2027 (USD Million)
    • 10.3.6 Asia Pacific: Anti-Viral Therapies Market, by Country, 2019 & 2027 (%)
    • 10.3.7 China: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.7.1 China: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.7.2 China: Anti-Viral Therapies Market, by Type, 2018-2027 (USD Million)
      • 10.3.7.3 China: Anti-Viral Therapies Market, by Mechanism of Action, 2018-2027 (USD Million)
      • 10.3.7.4 China: Anti-Viral Therapies Market, by Application, 2018-2027 (USD Million)
    • 10.3.8 Japan: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.8.1 Japan: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.8.2 Japan: Anti-Viral Therapies Market, by Type, 2018-2027 (USD Million)
      • 10.3.8.3 Japan: Anti-Viral Therapies Market, by Mechanism of Action, 2018-2027 (USD Million)
      • 10.3.8.4 Japan: Anti-Viral Therapies Market, by Application, 2018-2027 (USD Million)
    • 10.3.9 India: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.9.1 India: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.9.2 India: Anti-Viral Therapies Market, by Type, 2018-2027 (USD Million)
      • 10.3.9.3 India: Anti-Viral Therapies Market, by Mechanism of Action, 2018-2027 (USD Million)
      • 10.3.9.4 India: Anti-Viral Therapies Market, by Application, 2018-2027 (USD Million)
    • 10.3.10 South Korea: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.10.1 South Korea: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.10.2 South Korea: Anti-Viral Therapies Market, by Type, 2018-2027 (USD Million)
      • 10.3.10.3 South Korea: Anti-Viral Therapies Market, by Mechanism of Action, 2018-2027 (USD Million)
      • 10.3.10.4 South Korea: Anti-Viral Therapies Market, by Application, 2018-2027 (USD Million)
    • 10.3.11 Australia: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.11.1 Australia: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.11.2 Australia: Anti-Viral Therapies Market, by Type, 2018-2027 (USD Million)
      • 10.3.11.3 Australia: Anti-Viral Therapies Market, by Mechanism of Action, 2018-2027 (USD Million)
      • 10.3.11.4 Australia: Anti-Viral Therapies Market, by Application, 2018-2027 (USD Million)
  • 10.4 Middle East & Africa: Anti-Viral Therapies Market
    • 10.4.1 Overview
    • 10.4.2 Middle East & Africa: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (US$ Million)
    • 10.4.3 Middle East & Africa: Anti-Viral Therapies Market, by Type, 2018-2027 (USD Million)
    • 10.4.4 Middle East & Africa Anti-Viral Therapies Market, by Mechanism of Action - Revenue and Forecast to 2027 (USD Million)
    • 10.4.5 Middle East & Africa Anti-Viral Therapies Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 10.4.6 Middle East & Africa: Anti-Viral Therapies Market, by Country, 2019 & 2027 (%)
    • 10.4.7 Saudi Arabia: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.7.1 Saudi Arabia: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.7.2 Saudi Arabia: Anti-Viral Therapies Market, by Type, 2018-2027 (USD Million)
      • 10.4.7.3 Saudi Arabia Anti-Viral Therapies Market, by Mechanism of Action - Revenue and Forecast to 2027 (USD Million)
      • 10.4.7.4 Saudi Arabia Anti-Viral Therapies Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 10.4.8 UAE: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.8.1 UAE: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.8.2 UAE: Anti-Viral Therapies Market, by Type, 2018-2027 (USD Million)
      • 10.4.8.3 UAE Anti-Viral Therapies Market, by Mechanism of Action - Revenue and Forecast to 2027 (USD Million)
      • 10.4.8.4 UAE Anti-Viral Therapies Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 10.4.9 South Africa: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.9.1 South Africa: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.9.2 South Africa: Anti-Viral Therapies Market, by Type, 2018-2027 (USD Million)
      • 10.4.9.3 South Africa Anti-Viral Therapies Market, by Mechanism of Action - Revenue and Forecast to 2027 (USD Million)
      • 10.4.9.4 South Africa Anti-Viral Therapies Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • 10.5 South and Central America: Anti-Viral Therapies Market
    • 10.5.1 Overview
    • 10.5.2 South and Central America: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (US$ Million)
    • 10.5.3 South and Central America: Anti-Viral Therapies Market, by Type, 2018-2027 (USD Million)
    • 10.5.4 South and Central America: Anti-Viral Therapies Market, by Mechanism of Action, 2018-2027 (USD Million)
    • 10.5.5 South and Central America: Anti-Viral Therapies Market, by Application, 2018-2027 (USD Million)
    • 10.5.6 South and Central America: Anti-Viral Therapies Market, by Country, 2019 & 2027 (%)
    • 10.5.7 Brazil: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.7.1 Brazil: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.7.2 Brazil: Anti-Viral Therapies Market, by Type, 2018-2027 (USD Million)
      • 10.5.7.3 Brazil: Anti-Viral Therapies Market, by Mechanism of Action, 2018-2027 (USD Million)
      • 10.5.7.4 Brazil: Anti-Viral Therapies Market, by Application, 2018-2027 (USD Million)
    • 10.5.8 Argentina: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.8.1 Argentina: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.8.2 Argentina: Anti-Viral Therapies Market, by Type, 2018-2027 (USD Million)
      • 10.5.8.3 Argentina: Anti-Viral Therapies Market, by Mechanism of Action, 2018-2027 (USD Million)
      • 10.5.8.4 Argentina: Anti-Viral Therapies Market, by Application, 2018-2027 (USD Million)

11. Impact of COVID-19 Pandemic on Global Anti-Viral Therapies Market

  • 11.1 North America: Impact Assessment of COVID-19 Pandemic
  • 11.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 11.4 Rest of World: Impact Assessment of COVID-19 Pandemic

12. Anti-Viral Therapies Market - Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies Done by the Companies in the Market, (%)
  • 12.3 Organic Developments
    • 12.3.1 Overview
  • 12.4 Inorganic Developments
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Abbott
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 AbbVie Inc.
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Bristol-Myers Squibb Company
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Johnson and Johnson Services, Inc.
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Merck & Co., Inc.
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Gilead Sciences, Inc.
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 GlaxoSmithKline plc.
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 AstraZeneca
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Aurobindo Pharma Ltd
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 F. HOFFMANN-LA ROCHE LTD.
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.